Website Logo

Press

Keep up-to-date with relevant news, important announcements and key market insights.

READ MORE
FEATURED

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Download here

Press Release

About Bionical Emas

Bionical Emas is the only Contract Research Organization that combines Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) to deliver a unique, seamless approach to bring life-changing medicines to patients around the world.

READ MORE

The Guardian - Inviting patients as equal partners in the drug development process

News

READ MORE

Tom Watson appointed Chief Executive Officer

Press Release

READ MORE

Carl Hvass appointed Chief Financial Officer

Press Release

READ MORE

Medics 4 Rare Diseases - The Rare Disease Podcast 4 Medics

Resource

READ MORE

Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia

Resource

READ MORE

Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035

Press Release

READ MORE

Webinar: Operationalize Expanded Access Programs

Resource

READ MORE

Webinar: The International Rare Disease Showcase

Resource

READ MORE

Bionical Emas to establish European storage, distribution and labelling facility in Co. Westmeath

Press Release

READ MORE

Janssen Guide to Expanded Access

Resource

READ MORE

What is an Early Access Program?

Resource

READ MORE

Bionical Emas launches Expanded Access Program for JZP458 – a recombinant Erwinia Asparaginase

Press Release

1 / 3